Rates of spontaneous reporting of adverse drug reactions in France [3]

JAMA

Volumn 288, Issue 13, 2002, Pages 1588-

  Bégaud, Bernard ^a   Martin, Karin ^a   Haramburu, Françoise ^a   Moore, Nicholas ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; FRANCE; HUMAN; LETTER; MEDICAL LITERATURE; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; PUBLICATION;

EID: 0037009914     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.13.1588     Document Type: Letter

References (6)

1. Rossi AC, Knapp DE, Anello C, et al. Discovery of adverse drug reactions: a comparison of selected phase IV studies with spontaneous reporting methods. JAMA. 1983;249:2226-2228.
2. Lacoste-Roussillon C, Pouyanne P, Haramburu F, Miremont G, Bégaud B. Incidence of adverse drug reactions in general practice: a prospective study. Clin Pharmacol Ther. 2001;69:458-462.
3. Imbs J, Pouyanne P, Haramburu F, et al. Adverse drug reactions: prevalence in French public hospitals. Therapie. 1999;52:21-27.
4. Pouyanne P, Haramburu F, Imbs JL, Bégaud B. Admissions to hospital caused by adverse drug reactions: a cross-sectional incidence study: French pharmacovigilance centres. BMJ. 2000;320:1036.
5. Eland IA, Belton KJ, Van G rootheest AC, Meiners AP, Rawlins MD, Stricker BH Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48:623-627.
6. National Pharmacovigilance Systems. Country Profiles and Overview. 2nd ed. Uppsala, Sweden: Uppsala Monitoring Centre; 1999.